Target Name: MIR139
NCBI ID: G406931
Review Report on MIR139 Target / Biomarker Content of Review Report on MIR139 Target / Biomarker
MIR139
Other Name(s): microRNA 139 | mir-139 | MIRN139 | hsa-mir-139 | MIR139-3p | MicroRNA 139 | hsa-miR-139-3p | hsa-miR-139-5p

miRNA 139: A Non-Coding RNA Molecule with Potential Drug-Related Properties

MicroRNA 139 (miRNA 139) is a non-coding RNA molecule that plays a crucial role in various biological processes in the human body. It is made up of 20-22nt long hairpin RNA molecules and is usually expressed in a gene-specific manner. One of the most significant functions of miRNA 139 is its role in regulating gene expression. It has been shown to play a key role in the regulation of cell cycle progression, apoptosis, and tissue homeostasis.

In addition to its role in gene regulation, miRNA 139 has also been shown to have a number of potential drug-related properties. One of the most promising aspects of miRNA 139 is its potential as a drug target. Several studies have suggested that miRNA 139 may be a useful target for small molecule inhibitors because of its unique structure and the fact that it is expressed in a gene-specific manner.

One of the key features of miRNA 139 is its hairpin RNA structure. This structure gives the molecule a unique 3D shape that is able to interact with a variety of different molecules, including small molecules and proteins. The hairpin RNA structure also allows miRNA 139 to form a stable complex with its target protein, which is thought to play a key role in the regulation of gene expression.

Another potential drug-related property of MiRNA 139 is its expression. As mentioned earlier, MiRNA 139 is typically expressed in a gene-specific manner, which makes it a potential target for small molecule inhibitors. This is because the expression of MiRNA 139 is often sensitive to changes in the levels of its precursor, miR-139, which is a small RNA molecule that is derived from the microRNA 139 gene.

In addition to its potential as a drug target and its unique structure, miRNA 139 has also been shown to have a number of potential drug-related applications. For example, miRNA 139 has been shown to play a key role in the regulation of cell apoptosis. , which is the process by which cells die when they have reached their maximum number of copies and are no longer needed. Several studies have suggested that miRNA 139 may be a potential drug target for inhibitors of cell apoptosis because of its role in this process.

Another potential drug-related application of miRNA 139 is its role in the regulation of tissue homeostasis. Tissue homeostasis refers to the ability of tissues to maintain a stable internal environment that is necessary for proper function. miRNA 139 has been shown to play a key role in the regulation of tissue homeostasis by controlling the expression of genes that are involved in cell signaling and differentiation.

In conclusion, miRNA 139 is a non-coding RNA molecule that has a number of potential drug-related properties. Its unique hairpin RNA structure and its expression as a gene-specific molecule make it a promising target for small molecule inhibitors. Furthermore, miRNA 139 has been shown to play a key role in the regulation of cell apoptosis and tissue homeostasis, which makes it a potential drug target for compounds that are designed to inhibit these processes. Further research is needed to fully understand the potential drug-related applications of miRNA 139 and to develop safe and effective treatments based on its use.

Protein Name: MicroRNA 139

The "MIR139 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR139 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR140 | MIR141 | MIR142 | MIR143 | MIR144 | MIR145 | MIR1468 | MIR1469 | MIR146A | MIR146B | MIR1470 | MIR1471 | MIR147A | MIR147B | MIR148A | MIR148B | MIR149 | MIR150 | MIR151A | MIR151B | MIR152 | MIR153-1 | MIR153-2 | MIR1537 | MIR1538 | MIR1539 | MIR154 | MIR155 | MIR155HG | MIR1587 | MIR15A | MIR15B | MIR16-1 | MIR16-2 | MIR17 | MIR17HG | MIR181A1 | MIR181A1HG | MIR181A2 | MIR181A2HG | MIR181B1 | MIR181B2 | MIR181C | MIR181D | MIR182 | MIR1825 | MIR1827 | MIR183 | MIR184 | MIR185 | MIR186 | MIR187 | MIR188 | MIR18A | MIR18B | MIR1908 | MIR1909 | MIR190A | MIR190B | MIR191 | MIR1910 | MIR1911 | MIR1912 | MIR1913 | MIR1914 | MIR1915 | MIR1915HG | MIR192 | MIR193A | MIR193B | MIR193BHG | MIR194-1 | MIR194-2 | MIR194-2HG | MIR195 | MIR196A1 | MIR196A2 | MIR196B | MIR197 | MIR1972-1 | MIR1972-2 | MIR1973 | MIR1976 | MIR198 | MIR199A1 | MIR199A2 | MIR199B | MIR19A | MIR19B1 | MIR19B2 | MIR200A | MIR200B | MIR200C | MIR200CHG | MIR202 | MIR202HG | MIR203A | MIR203B | MIR204 | MIR205